NCT06666335View on ClinicalTrials.gov

A Study to Evaluate Efficacy and Safety of Anakinra in Chinese Patients With Colchicine-resistent FMF

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

August 30, 2027

Study Completion Date

November 30, 2027

Conditions
Familial Mediterranean Fever (FMF )
Interventions
DRUG

Anakinra

Subcutaneous injections once daily for 6 months

Sponsors
All Listed Sponsors
collaborator

Tigermed Consulting Co., Ltd

INDUSTRY

lead

Swedish Orphan Biovitrum

INDUSTRY